A new class of drugs that inhibit platelet release and aggregation.
D000838:Anions / Q000378:metabolism; D001692:Biological Transport / Q000187:drug effects; D001792:Blood Platelets / Q000378:metabolism*; D005089:Exocytosis / Q000187:drug effects; D005665:Furosemide / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D009994:Osmolar Concentration; D010974:Platelet Aggregation / Q000187:drug effects*; D011339:Probenecid / Q000494:pharmacology; D011732:Pyridoxal Phosphate / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D013442:Sulfinpyrazone / Q000494:pharmacology; D013498:Suramin / Q000494:pharmacology; D013917:Thrombin / Q000378:metabolism
D000838:Anions; D012701:Serotonin; D011732:Pyridoxal Phosphate; D013498:Suramin; D005665:Furosemide; D013917:Thrombin; D011339:Probenecid; D013442:Sulfinpyrazone